Munich Reinsurance Co Stock Corp in Munich Acquires Shares of 15,084 Celestica, Inc. $CLS

Munich Reinsurance Co Stock Corp in Munich bought a new stake in Celestica, Inc. (NYSE:CLS) (TSE:CLS) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 15,084 shares of the technology company’s stock, valued at approximately $5,499,000.

Other institutional investors have also recently made changes to their positions in the company. TD Waterhouse Canada Inc. boosted its stake in shares of Celestica by 14.3% during the 2nd quarter. TD Waterhouse Canada Inc. now owns 135,663 shares of the technology company’s stock worth $49,023,000 after purchasing an additional 16,961 shares during the period. United Community Bank bought a new stake in Celestica in the second quarter worth about $100,000. Concurrent Investment Advisors LLC boosted its position in shares of Celestica by 8.4% during the second quarter. Concurrent Investment Advisors LLC now owns 1,899 shares of the technology company’s stock valued at $693,000 after buying an additional 147 shares during the period. Continuum Advisory LLC purchased a new position in shares of Celestica during the second quarter valued at approximately $62,000. Finally, Nykredit A S bought a new position in shares of Celestica during the second quarter valued at approximately $11,542,000. Institutional investors own 67.38% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Robert Mionis sold 98,453 shares of the business’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $368.99, for a total value of $36,328,172.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Mandeep Chawla sold 17,000 shares of the company’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $399.65, for a total value of $6,794,050.00. Following the sale, the chief financial officer owned 82,444 shares of the company’s stock, valued at $32,948,744.60. This trade represents a 17.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 356,553 shares of company stock worth $135,238,444 over the last quarter. Company insiders own 1.10% of the company’s stock.

Celestica Price Performance

NYSE CLS opened at $312.84 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.68 and a current ratio of 1.23. The firm’s 50 day moving average price is $327.47 and its 200-day moving average price is $335.77. Celestica, Inc. has a 52-week low of $227.00 and a 52-week high of $474.02. The company has a market cap of $35.97 billion, a PE ratio of 32.52 and a beta of 2.04.

Celestica (NYSE:CLS) (TSE:CLS) last issued its quarterly earnings data on Monday, July 27th. The technology company reported $2.54 EPS for the quarter, topping analysts’ consensus estimates of $2.29 by $0.25. The company had revenue of $4.68 billion during the quarter, compared to the consensus estimate of $4.30 billion. Celestica had a net margin of 7.16% and a return on equity of 39.96%. Celestica’s revenue for the quarter was up 62.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.39 earnings per share. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. Sell-side analysts forecast that Celestica, Inc. will post 10.71 EPS for the current fiscal year.

Analyst Ratings Changes

CLS has been the subject of a number of recent analyst reports. Wolfe Research boosted their price objective on Celestica from $425.00 to $475.00 and gave the company an “outperform” rating in a report on Wednesday, July 29th. Canadian Imperial Bank of Commerce boosted their price objective on shares of Celestica from $480.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, July 29th. Royal Bank Of Canada set a $450.00 target price on shares of Celestica and gave the stock an “outperform” rating in a research report on Wednesday, August 26th. Bank of America reiterated a “buy” rating on shares of Celestica in a report on Wednesday, July 29th. Finally, Stifel Nicolaus set a $500.00 target price on Celestica in a research report on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $439.81.

Celestica Company Profile

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.